757
Views
10
CrossRef citations to date
0
Altmetric
Laboratory Studies

Protective Effect of Prostaglandin E1 on Renal Microvascular Injury in Rats of Acute Aristolochic Acid Nephropathy

, , &
Pages 225-232 | Received 12 Oct 2010, Accepted 09 Nov 2010, Published online: 18 Feb 2011

REFERENCES

  • Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: A worldwide problem. Kidney Int. 2008;74(2): 158–169.
  • Vanherweghem JL, Depierreux M, Tielemans C, Rapidly progressive interstitial fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet. 1993; 341:387–391.
  • Reginster F, Jadoul M, van Ypersele de Strihou C. Chinese herbs nephropathy presentation, natural history, and fate after transplantation. Nephrol Dial Transplant. 1997;12:81–86.
  • Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis. 1994;24:172–180.
  • Cosyns JP, Dehoux JP, Guiot Y, Chronic aristolochic acid toxicity in rabbits: A model of Chinese herbs nephropathy? Kidney Int. 2001;59:2164–2173.
  • Yang CS, Lin CH, Chang SH, Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis. 2000;35:313–318.
  • Yang L, Li X, Wang H. Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis. Nephrol Dial Transplant. 2007; 22:445–456.
  • Sun D, Feng J, Dai C, Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy. Am J Nephrol. 2006; 26:363–371.
  • Weiss T, Eckstein H, Weiss C, Diehm C. Neutrophil function in peripheral arterial occlusive disease: The effects of prostaglandin E1. Vasc Med. 1998;3:171–175.
  • Kelly CJ, Zurier RB, Krakauer KA, Blanchard N, Neilson EG. Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis. J Clin Invest. 1987;79(3):782–789.
  • Sun D, Feng JM, Zhao YL, Jin T, Wang LN. Effects of prostaglandin E1 on the progression of aristolochic acid nephropathy. Chin Med Sci J. 2005;20:67–69.
  • Kang DH, Joly AH, Oh SW, Impaired angiogenesis in the remnant kidney model (I): Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol. 2001;12:1434–1447.
  • Debelle FD, Nortier JL, Husson CP, The renin-angiotensin system blockade does not prevent renal interstitial fibrosis induced by aristolochic acids. Kidney Int. 2004;66: 1815–1825.
  • Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: A pilot study in Chinese herbs nephropathy. Am J Kidney Dis. 1996;27: 209–215.
  • Yang L, Li XM, Wang SX, Wang HY. Peritubular capillary injury in Chinese herb guan-mu-tong-induced acute tubular necrosis. Chin J Intern Med. 2005;44:525–529.
  • Choi YJ, Chakraborty S, Nguyen V, Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular enthelial growth factor. Hum Pathol. 2000;31(12):1491–1497.
  • Stravodimos KG, Koritsiadis G, Lazaris AC. Hydronephrosis promotes expression of hypoxia-inducible factor 1α. Urol Int. 2009;82:38–42.
  • Safran M, Kaelin WG Jr. HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest. 2003;111(6):779–783.
  • Kairaitis LK, Wang Y, Gassmann M, Tay YC, Harris DC. HIF-1alpha expression follows micro vascular loss in advanced murine Adriamycin nephrosis. Am J Physiol Renal Physiol. 2005;288(1):F198–F206.
  • Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis. Acta Hematol. 2001;106:148–156.
  • Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9–22.
  • Nakamura M, Yamabe H, Osawa H, Hypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in culture. Nephrol Dial Transplant. 2006;21:1489–1495.
  • Akiyama H, Tanaka T, Maeno, T, Induction of VEGF gene expression by retinoic acid through SP1-binding sites in retinoblastoma Y79 cells. Invest Ophthalmol Vis Sci. 2002; 43(5):1367–1374.
  • Okada F, Rak JW, Croix BS, Impact of oncogenes in tumor angiogenesis: Mutant K-rats up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci USA. 1998,95:3609–3614.
  • Kramer BK, Bucher M, Sandner P, Effects of hypoxia on growth factor expression in the rat kidney in vivo. Kidney Int. 1997;51:444–447.
  • Sandner P, Wolf K, Bergmaier U, Gess B, Kurtz A. Induction of VEGF and VEGF receptor gene expression by hypoxia: Divergent regulation in vivo and in vitro. Kidney Int. 1997;51:448–453.
  • Katavetin P, Miyata T, Inagi R, High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway. J Am Soc Nephrol. 2006;17: 1405–1413.
  • Nabeshima M, Moriyasu F, Nishikawa K, Evaluation of protective effects of prostaglandin E1 on ischemic liver damage with in vivo 31P-MR spectroscopy. Magn Reson Med. 1995;34(3):457–461.
  • Nakai M, Uchida H, Hanaoka T, Sugiyama S, Sano S, Shimizu N. Beneficial effects of prostaglandin E1 on ischemic colitis following surgery on the abdominal aorta. Surg Today. 1998;28(11):1146–1153.
  • Han R, Gao B, Sheng R, Synergistic effects of prostaglandin E1 and lithium in a rat model of cerebral ischemia. Acta Pharmacol Sin. 2008;29(10):1141–1149.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.